NANO4TARMED is a brand that brings together a diverse group of chemists, biologists, and physicists in an interdisciplinary scientific cluster. With their extensive expertise, they aim to address the fundamental issue of nanotechnology-driven anticancer drug delivery. As cancer remains a leading cause of death worldwide, the need for new therapeutic strategies is crucial.

NANO4TARMED focuses on the combination therapy using nanocarriers, allowing for the simultaneous administration of multiple pharmacologically active agents with different modes of action. By selectively targeting diseased tissue and overcoming biological barriers, their therapeutic formulations increase efficacy. The brand's interest in employing nanostructured materials in medicine-related fields comes from their unique properties that enable highly efficient drug delivery, molecular sensing, and the construction of therapeutic devices.

Through workshops, seminars, and exchanges of early-stage researchers, NANO4TARMED aims to develop a consortium that specializes in functional 3D dual-modality nanostructures for targeted drug delivery and cell imaging. This project, funded by the European Union's Horizon 2020 program, promotes open science models and aims to make impactful contributions to the field of nanotechnology-driven anticancer drug delivery